Avadel Pharmaceuticals PLC (AD - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AVDL Nasdaq 2834 http://www.avadel.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avadel Pharmaceuticals PLC (AD

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - May 31st, 2018 2:01 pm
Analysis: Positioning to Benefit within Avadel Pharmaceuticals, Abeona Therapeutics, BanColombia S.A, Aercap Holdings N.V, Kite Realty Group Trust, and Credicorp — Research Highlights Growth, Revenue, and Consolidated Results - May 31st, 2018 6:30 am
Free Technical Insights on CASI Pharma and Three Other Biotech Stocks - May 31st, 2018 6:30 am
Avadel to Present Late-Breaker Data and Product Theater Forum at the 2018 American Urological Association Annual Meeting - May 18th, 2018 9:00 am
Avadel: 1Q Earnings Snapshot - May 2nd, 2018 7:26 am
Avadel Pharmaceuticals Reports First Quarter 2018 Results - May 2nd, 2018 5:30 am
Avadel Launches NOCTIVA™, the First and Only FDA-Approved Treatment for Nocturia Due to Nocturnal Polyuria - May 1st, 2018 7:43 am
Avadel Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference - Apr 30th, 2018 2:01 pm
Avadel Pharmaceuticals to Report First Quarter 2018 Results - Apr 24th, 2018 5:30 am
Avadel Pharmaceuticals plc (NASDAQ:AVDL): What’s The Analyst Consensus Outlook? - Apr 17th, 2018 1:41 pm
Detailed Research: Economic Perspectives on VASCO Data Security International, Constellation Brands, MYOS RENS Technology, Avadel Pharmaceuticals, Energizer, and BJ's Restaurants — What Drives Growth in Today's Competitive Landscape - Apr 6th, 2018 5:55 am
Avadel Pharmaceuticals Announces Acceptance of Late-Breaker Presentation for NOCTIVA™ at the 2018 American Urological Association - Apr 3rd, 2018 5:30 am
Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer - Mar 22nd, 2018 5:30 am
Jazz Pharma Upgraded On Bullish Pipeline Forecast, Earnings Growth Visibility, M&A Potential - Mar 19th, 2018 7:37 am
Avadel reports 4Q loss - Mar 8th, 2018 7:45 am
Here's Why Avadel Pharmaceuticals Dropped as Much as 13.3% Today - Feb 14th, 2018 2:34 pm